Ada is a digital health company created by doctors to improve human health by transforming knowledge into better outcomes.
Ada helps you and your loved ones check symptoms and discover what might be causing them – day or night without an appointment.
Ada was founded in 2011 by Claire Novorol, Daniel Nathrath, and Dr. Martin Hirsch. The company is based in Berlin, with offices in New York, London and Munich.
Ada has developed a powerful AI-based health assessment and care navigation platform that helps users to understand their symptoms, to identify and differentiate conditions with a high degree of medical accuracy, and to navigate safely to the right care, at the right time.
Ada's core system connects medical knowledge with intelligent technology to help all people actively manage their health and medical professionals to deliver effective care, and the company works with leading health providers and organizations to carry out this vision.
The Ada platform has over 11 million users worldwide and has completed over 23 million assessments since its global launch in 2016.
Ada is backed by Leaps by Bayer, Samsung Catalyst Fund, Farallon Capital, Red River West, Vitruvian Partners, Cumberland VC, Access Technology Ventures, Inteligo Bank, F4, Mutschler Ventures, and others. The company raised an additional $30M to its Series B on Feb 10, 2022. This is an extension of their previous $90M Series B raised in May 2021, bringing the round total to $120M. The additional investment brings Ada's total funding to $189.3M to date.